E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/18/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

OrthoLogic will not require investor to buy another $1.5 million of stock

By Sheri Kasprzak

New York, Sept. 18 - OrthoLogic Corp. said it will not require PharmaBio Development Inc. to buy another $1.5 million in stock as part of a previous stock offering settled in February.

Under the terms of the previous placement, OrthoLogic had the option to require PharmaBio, doing business as NovaQuest, to buy another $1.5 million of stock before Sept. 30.

In the original offering, which closed Feb. 27, NovaQuest bought 1,262,531 shares for proceeds of $3.5 million.

Based in Tempe, Ariz., OrthoLogic develops therapies for orthopedic ailments.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.